Written and maintained by CASRAI Editorial Board
Last updated
Short answer. The CAG promoter is a hybrid mammalian expression element that combines the cytomegalovirus (CMV) early enhancer with the chicken beta-actin promoter. It is widely used to drive strong, broad transgene expression, and the plasmid name pCAGGS (“CAGGS promoter”) refers to the vector that carries it. This page is general reference for researchers and lab staff, not a protocol.
Definition and scope
The name CAG is a shorthand for the CMV early enhancer / chicken beta-actin combination. A 2008 study in BMC Cell Biology describes it exactly that way: “the CMV early enhancer/chicken beta actin (CAG) promoter” (Alexopoulou, Couchman and Whiteford, PMID 18190688, read 2026-11-08). The element is regulatory DNA that sits upstream of the coding sequence you want expressed, so it is one design decision among several when you build a construct (see plasmid design: backbone, promoter, marker and tags).
CAG promoter vs CAGGS promoter vs pCAGGS
These labels are used interchangeably in searches, but they point at slightly different things. “CAG promoter” is the regulatory element. “pCAGGS” is a named expression plasmid backbone; the Addgene record for plasmid 203326 (pCAGGS-mCherry-C, read 2026-11-08) lists its promoter as “CAG”, the backbone as pCAGGS at 5,504 bp, and credits the original plasmid to Niwa et al., Gene 1991. When a catalogue or paper says “CAGGS promoter”, it is normally the promoter of that vector family.
Where the name comes from
The original vector was reported by Niwa H, Yamamura K and Miyazaki J in Gene 1991;108(2):193-199 (PMID 1660837, read 2026-11-08). Their abstract describes “a ubiquitously strong promoter based on the beta-actin promoter” in a vector built for selecting high-expression transfectants. The same vector combined a subregion of the bovine papilloma virus genome with a mutant neomycin phosphotransferase II gene driven by a weak promoter, so that only cells carrying many copies survive G418 selection; the authors report that about 800 ug/ml G418 selected transfectants with more than 300 vector copies. They tested it with human interleukin-2 in L cells and CHO cells and found the vector integrated into the host chromosome and stayed stable for several months.
Two points are worth keeping apart. First, that abstract does not itself use the label “CAG”; the label came into use for the promoter element later. Second, the high-copy selection design is a property of that original vector, not something every CAG-containing plasmid does. A CAG cassette inside a different backbone is simply a promoter choice.
How it is used in practice: one documented comparison with CMV and beta-actin alone
Strong viral promoters can lose activity in some cell contexts. In the BMC Cell Biology study, murine embryonic stem (ES) cells were hard to transfect, and activity of both the CMV promoter and the beta-actin promoter was downregulated during selection of stable transfectants and again during differentiation toward the Flk1 stage. With the CMV immediate enhancer / beta-actin promoter in the pCAGIPuro-GFP construct, all (100%) of stably transfected undifferentiated and differentiated cells expressed GFP, and the syndecan-2 and syndecan-4 transgenes were highly expressed. The authors concluded that CAG-based vectors are valuable for long-term transgene expression during ES cell differentiation toward mesoderm, while CMV or beta-actin alone gave very poor expression.
| Promoter in the study | Reported outcome in murine ES cells and differentiation to Flk1 stage |
|---|---|
| CMV alone | Activity downregulated during stable selection and differentiation; very poor expression |
| Beta-actin alone | Activity downregulated during stable selection and differentiation; very poor expression |
| CAG (CMV enhancer + beta-actin promoter) | 100% of stably transfected cells GFP-positive, undifferentiated and differentiated |
This is a single study in one cell system. It supports the statement that CAG held up where its two parent elements did not in that setting; it does not rank promoters across cell types, species or vectors.
Where it matters for labs
CAG is common in reporter and conditional-allele designs where a ubiquitously active promoter is wanted. A familiar example is the Cre reporter pattern described in the lox-stop-lox guide, where a CAG-driven cassette is held silent by a floxed stop until Cre acts; Cre driver choice is covered in conditional knockout driver lines.
Checklist: reading the promoter field on a plasmid record
- Promoter field. Addgene record 203326 shows “CAG”. Treat it as the label, then confirm against the depositor’s reference.
- Backbone and size. The same record names the pCAGGS backbone and 5,504 bp, which tells you which vector family you are looking at.
- Attribution. The depositor credits Niwa et al., Gene 1991, as the original plasmid source.
- Translation and insert design. The record lists a Kozak sequence (GCCACCATGG), the mCherry coding sequence and a multiple cloning site inserted by In-Fusion, so the promoter is only one of several fields to read.
- Bacterial propagation. The record lists ampicillin resistance, high copy number and DH5alpha grown at 37 C, which are separate from how the promoter behaves in mammalian cells.
Common misunderstandings
- “CAG means a pure chicken promoter.” The name covers a hybrid of a CMV enhancer and a chicken beta-actin promoter.
- “CAGGS and CAG are different promoters.” They are used for the same element family; CAGGS is tied to the pCAGGS vector name. Descriptions of exactly which additional intron or globin-derived sequences are included vary between sources, so check the vector map of the plasmid you are actually using.
- “Strong means active everywhere, always.” The study above shows the opposite problem for CMV and beta-actin alone; activity depends on context, and one study is not a universal rule.
FAQ
What is the CAG promoter?
A hybrid promoter combining the CMV early enhancer with the chicken beta-actin promoter, used to drive strong expression of a transgene in mammalian cells.
What is the CAGGS promoter?
The promoter of the pCAGGS expression vector family, which traces to Niwa, Yamamura and Miyazaki, Gene 1991.
Is the CAG promoter ubiquitous?
The 1991 report describes the beta-actin-based promoter as ubiquitously strong, and the 2008 ES cell study showed sustained expression through differentiation. Neither source establishes activity in every tissue or cell type.
Sources
- Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108(2):193-199. PubMed PMID 1660837, read 2026-11-08.
- Alexopoulou AN, Couchman JR, Whiteford JR. The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 2008;9:2. PMID 18190688, PMC2254385, read 2026-11-08.
- Addgene, plasmid 203326, pCAGGS-mCherry-C (addgene.org/203326/), read 2026-11-08.
